FDA Inspection 780431 — Eurofins Biopharma Product Testing, Denmark A/S

Eurofins Biopharma Product Testing, Denmark A/S — FEI 3006272083

The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on Mar 30, 2012 in Glostrup. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 30, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glostrup (Denmark)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.